ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1940

Investigating the Post-Partum Flare in Rheumatoid Arthritis Using Transcriptome Analysis

Matthew Wright1, Dana Goin 2, Mette Smed 3, Lior Pachter 4, J. Lee Nelson 5, Nicholas Jewell 6, Jørn Olsen 7, Merete Lund Hetland 8, Vibeke Zoffmann 9 and Damini Jawaheer 10, 1UCSF Benioff Children's Hopsital Oakland, Oakland, 2UCSF Benioff Children's Hospital Oakland, Oakland, 3Juliane Marie Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark, 4Caltech, Pasadena, 5Fred Hutchinson Cancer Research Center, Seattle, 6University of California Berkeley, Berkeley, 7Aarhus University Hospital, Aarhus, Denmark, 8DANBIO and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopaedics, Rigshospitalet, Copenhagen, Denmark, 9Juliane Marie Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen, 10UCSF Benioff Children's Hospital Oakland, Oakland, CA

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: pregnancy and Gene Expression, Rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: Genetics, Genomics & Proteomics Poster

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Women with Rheumatoid arthritis (RA) tend to have a predictable flare of disease activity in the months after childbirth. The mechanism(s) underlying this post-partum flare are as yet unknown. Using our pregnancy cohort, we (a) examined gene expression changes associated with a flare of RA disease activity post-partum, (b) determined how those changes compare to post-partum changes observed among healthy women, and (c) examined whether expression profiles by 3 months post-partum differed from those before pregnancy.

Methods: Ten women with RA and five healthy women were enrolled in our pregnancy cohort and prospectively followed. Data on joint counts and global scores were collected from the women with RA before pregnancy (T0), at the third trimester (T3) and every 3 months post-partum (PP), and used to assess disease activity. Blood samples were drawn from all women at each time-point. Total RNA was isolated and used for RNA sequencing (RNA-seq). Pseudo-alignment and quantification of the raw RNA-seq reads were performed using kallisto. Differentially expressed (DE) genes were identified with edgeR using a significance threshold of q≤0.05 and fold-change≥2. Longitudinal mixed linear models were also used to test for associations between gene expression and disease activity post-partum. Functional analyses were performed using Cytoscape and ClueGO.

Results: Among the women with RA, 133 genes were DE between T3 and 3 months PP, when there was a flare of disease activity. These included genes encoding cell surface receptors CD24, CD177 and PD-L1, defensins, immunoglobulin receptors, S100 calcium binding proteins, and TRIM proteins. Functionally, these genes were enriched in the Gene Ontology (GO) terms neutrophil activation (q=1.1e-16) and antimicrobial humoral response (q=1.4e-5). Of the 133 DE genes, 118 were also DE among healthy women between T3 and 3 months PP, with expression changing in the same direction in both RA and healthy women. Similar results were obtained when the PP time-point with maximal disease activity during the flare was used (instead of 3 months PP). In the mixed linear model, 64 genes had expression patterns significantly associated with RA disease activity post-partum; these were enriched in various immune-related pathways including complement and coagulation cascades and systemic lupus erythematosus.  At 3 months PP, the gene expression profile among the women with RA differed from that at T0, with 61 genes DE between the 2 time-points. Among healthy women, however, there were no statistically significant changes in gene expression between T0 and 3 months PP, although some immune-related genes (n=24) were under-expressed by at least two-fold at 3 months PP compared to T0.

Conclusion: The large majority of gene expression changes between 3rd trimester and 3 months post-partum in RA reflect normal post-partum changes also seen among healthy women. Nonetheless, there are a set of immune-related genes whose expression appear to be influencing disease activity during the post-partum flare. Further, our results show that the RA expression profile at 3 months post-partum is distinct from that before pregnancy.


Disclosure: M. Wright, None; D. Goin, None; M. Smed, None; L. Pachter, None; J. Nelson, None; N. Jewell, None; J. Olsen, None; M. Lund Hetland, Abbvie, 2, AbbVie, 2, Biogen, 2, BMS, 2, CellTrion, 2, 9, MSD, 2, Novartis, 2, Orion, 2, Pfizer, 2, Samsung, 2, UCB, 2; V. Zoffmann, None; D. Jawaheer, None.

To cite this abstract in AMA style:

Wright M, Goin D, Smed M, Pachter L, Nelson J, Jewell N, Olsen J, Lund Hetland M, Zoffmann V, Jawaheer D. Investigating the Post-Partum Flare in Rheumatoid Arthritis Using Transcriptome Analysis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/investigating-the-post-partum-flare-in-rheumatoid-arthritis-using-transcriptome-analysis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/investigating-the-post-partum-flare-in-rheumatoid-arthritis-using-transcriptome-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology